DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

The state of DNA synthesis is a bit like humanity’s journey to the moon—just because something has been achieved before doesn’t mean we should cease figuring out how to do it better.” That is how ...

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology in preparation for customer use and commercialization. EVONETIX LTD (‘Evonetix’), the ...

“The state of DNA synthesis is a bit like humanity’s journey to the moon—just because something has been achieved before doesn’t mean we should cease figuring out how to do it better.” That is how ...

Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...

Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos that are up to 120 nt long in less than a day ...

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the ...

EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announces the introduction of new branding to align with its vision to ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "DNA synthesis markets, 2035 - Distribution by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose ...

The biosecurity risks associated with an unregulated industry became evident when, in 2006, a Guardian reporter successfully ordered parts of the smallpox genome through the mail. Although ordering ...